Oncology Site of Care Cost Differences & Solutions
On Thursday, November 16th the Community Oncology Alliance (COA), Florida Cancer Specialists & Research Institute (FCS), and Oncology Business Review (OBR) hosted a free webinar to discuss recent research into the cost differences between hospitals and community oncology practices, and how public policy can be changed to address it.
Results of a recent study release by COA shows that the total cost of care for cancer patients receiving chemotherapy delivered in the hospital outpatient setting is nearly 60%, or $90,144 per year, more expensive than the same treatment delivered in independent, community oncology practices. The analysis also found that rates of ED visits by cancer patients following chemotherapy were also higher in the hospital outpatient setting than the community practices.
On this free, live webinar, study researchers and COA joined OBR to discuss the study findings, site of service costs and differences, the impact this has on our cancer care system, and potential solutions. Study author Lucio Gordan, MD, from FCS, was joined by Ted Okon, executive director of COA to discuss the study fundings. The lively and interactive conversation was moderated by Don Sharpe, president of OBR.